Biofield Corp \De\ Sample Contracts

BIOFIELD CORP. STOCK OPTION AGREEMENT
Stock Option Agreement • March 30th, 1998 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware
AutoNDA by SimpleDocs
EXHIBIT 10.22 MRB INVESTOR RELATIONS, LLC
Service Agreement • March 30th, 2004 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • New York
WITNESSETH:
Lease Agreement • March 30th, 1998 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Georgia
WITNESSETH
Consulting Agreement • April 15th, 2003 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • California
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF BIOFIELD CORPORATION
Warrant Agreement • September 14th, 2004 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Florida
AGREEMENT
Agreement • July 29th, 1998 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • New York
OF
Subscription Agreement • December 19th, 2003 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Georgia
ARTICLE 2 REPRESENTATIONS AND WARRANTIES
Stock Purchase Agreement • August 11th, 2000 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • New York
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF BIOFIELD CORPORATION
Warrant Agreement • September 14th, 2004 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Florida
CHANGE IN TERMS AGREEMENT
Change in Terms Agreement • March 30th, 2004 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • California
RESERVE EQUITY FINANCING AGREEMENT
Reserve Equity Financing Agreement • August 16th, 2010 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • New York

THIS AGREEMENT dated as of the 22nd day of June 2010 (the “Agreement”) between AGS Capital Group, LLC a New York limited liability company (the “Investor”), and Biofield Corporation a corporation organized and existing under the laws of the State of Delaware (the “Company”).

WITNESSETH
Strategic Partnership Agreement • August 22nd, 2005 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware
EXECUTIVE EMPLOYMENT AGREEMENT
Executive Employment Agreement • November 19th, 2008 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Pennsylvania

This Executive Employment Agreement (“Agreement”) is entered into this 15th day of September, 2008 by and between (1) BIOFIELD CORP. (“BZEC” or the “Company”), a Delaware public corporation; and (2) STEVEN WASZAK (“Executive”).

Exhibit 99.2 BIOFIELD CORP. SHARE OPTION AGREEMENT
Share Option Agreement • February 27th, 2006 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware
STOCK ACQUISITION AND VOTING AGREEMENT
Stock Acquisition and Voting Agreement • April 6th, 2006 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware

The MacKay Group, Inc. (“MKG”), a corporation duly authorized and incorporated under Hong Kong law, with offices at 1615 Walnut Street, 3rd Floor, Philadelphia, Pennsylvania 19103; and

AutoNDA by SimpleDocs
CONSULTING AGREEMENT
Consulting Agreement • April 6th, 2006 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Pennsylvania

­­­30th day of March, 2006 (the “Effective Date”) by and between (1) The MacKay Group, Inc. ("MKG"), a corporation duly authorized and incorporated under Hong Kong law, with offices at 1615 Walnut Street, 3rd Floor, Philadelphia, Pennsylvania 19103; and (2) David M. Long, Jr. (“Dr. Long”), an adult individual residing at 10988 Horizon Hills Drive, El Cajon, California 92020.

OF
Subscription Agreement • September 14th, 2004 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Georgia
STOCK ACQUISITION AGREEMENT
Stock Acquisition Agreement • April 6th, 2006 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware

The MacKay Group, Inc. (“MKG”), a corporation duly authorized and incorporated under Hong Kong law, with offices at 1615 Walnut Street, 3rd Floor, Philadelphia, Pennsylvania 19103; and

ARTICLE 2 REPRESENTATIONS AND WARRANTIES
Stock Purchase Agreement • August 11th, 2000 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware
RECITALS
Escrow Agreement • August 11th, 2000 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • New York
Exhibit 99.1 BIOFIELD CORP. SHARE OPTION AGREEMENT
Share Option Agreement • March 2nd, 2006 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Delaware
EXCLUSIVE AGREEMENT FOR LICENSE AND TRANSFER OF IP
Exclusive Agreement • August 16th, 2010 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Georgia

THIS AGREEMENT is made and entered into as of the date last entered below and upon the payment of $250,000 to Guided Therapeutics, Inc. ("GT") (as set forth below), which payment must be made to GT no later than January 30, 2011 and $20,000 to GT for previous services provided, which payment must be made to GT by no later than August 15, 2010 ("the Effective Date"), by and between Mark L. Faupel, Ph.D., an individual having an address of 160 Foalgarth Way, Alpharetta, Georgia 30022 ("DR. FAUPEL") and Biofield Corp., a Delaware corporation, having an office at 175 Strafford Avenue, Wayne, PA 19087 ("BZEC").

VOTING AGREEMENT
Voting Agreement • October 8th, 2009 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Pennsylvania

VOTING AGREEMENT, dated as of September __, 2009, between James MacKay (“MacKay”), individually, and ValiRx Plc. (“ValiRx”), (each, a "Shareholder" and together, the "Shareholders").

ValiBio SA as Supplier and B10FIELD CORP. as Distributor
Exclusive Distribution Agreement • April 13th, 2009 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Hong Kong
AGREEMENT FOR RE-ENGINEERING AND MANUFACTURE OF NEW BDS DEVICE
Agreement • August 16th, 2010 • Biofield Corp \De\ • Electromedical & electrotherapeutic apparatus • Georgia

THIS AGREEMENT is made and entered into as of the date last entered below and upon the payment of $20,000 to GT for previous services provided, which payments must be made to GT by no later than August 15, 2010 ("the Effective Date"), by and between Guided Therapeutics, Inc. ("GT"), a corporation having an address of 5835 Peachtree Corners East, Suite D, Norcross, GA 30092 and Biofield Corp. ("BZEC"), a Delaware corporation, having an office at 175 Strafford Avenue, Wayne, PA 19087. In addition, prior to commencing work on the subject project, GT shall receive a further payment from BZEC of $250,000 towards the re-engineering and development of that certain BDS technology, which payment must be made to GT no later than January 30, 2011.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!